SC Retrasib SA announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was RON 148.821 million compared to RON 109.071 million a year ago. Operating income was RON 2.932 million compared to operating loss of RON 408,154 a year ago. Net loss was RON 1.237 million compared to RON 2.649 million a year ago. Basic loss per share from continuing operations was RON 0.265 compared to RON 0.026 a year ago.